tiprankstipranks
Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market
OBIO
Orchestra BioMed Holdings
RESEARCH TOOLSreports

Orchestra BioMed Holdings (OBIO) Cash flow

99 Followers

Orchestra BioMed Holdings Cash Flow

OBIO's free cash flow for Q4 2025 was $-2.30M. For the 2025 fiscal year, OBIO's free cash flow was decreased by $1.40M and operating cash flow was $-2.27M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Mar 25Dec 23Dec 22Dec 21
Operating Cash Flow
$ -48.96M$ -50.56M$ -46.13M$ -29.29M$ -19.43M
Investing Cash Flow
$ -26.94M$ 13.09M$ 10.69M$ -64.12M$ 13.02M
Financing Cash Flow
$ 88.33M$ 29.17M$ 46.22M$ 103.26M$ -3.99M
End Cash Position
$ 34.69M$ 22.26M$ 30.56M$ 19.78M$ 9.94M
Free Cash Flow
$ -49.45M$ -50.85M$ -46.20M$ -29.88M$ -19.70M
Currency in USD

Orchestra BioMed Holdings Cash Flow